BLyS and B cell autoimmunity

Curr Dir Autoimmun. 2003;6:21-37. doi: 10.1159/000066854.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / genetics
  • Arthritis, Rheumatoid / immunology
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology
  • Autoimmunity / immunology*
  • B-Cell Activating Factor
  • B-Cell Activation Factor Receptor
  • B-Cell Maturation Antigen
  • B-Lymphocyte Subsets / immunology*
  • Drug Design
  • Humans
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / genetics
  • Lupus Erythematosus, Systemic / immunology
  • Membrane Proteins / blood
  • Membrane Proteins / genetics
  • Membrane Proteins / physiology*
  • Mice
  • Mice, Inbred MRL lpr
  • Mice, Inbred NZB
  • Mice, Transgenic
  • Multigene Family
  • Receptors, Tumor Necrosis Factor / physiology
  • Signal Transduction
  • Transmembrane Activator and CAML Interactor Protein
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Autoantibodies
  • B-Cell Activating Factor
  • B-Cell Activation Factor Receptor
  • B-Cell Maturation Antigen
  • BLyS receptor
  • Membrane Proteins
  • Receptors, Tumor Necrosis Factor
  • TNFRSF13B protein, human
  • TNFRSF13C protein, human
  • TNFRSF17 protein, human
  • TNFSF13B protein, human
  • Tnfrsf13b protein, mouse
  • Tnfrsf13c protein, mouse
  • Tnfrsf17 protein, mouse
  • Tnfsf13b protein, mouse
  • Transmembrane Activator and CAML Interactor Protein
  • Tumor Necrosis Factor-alpha